The Problem

Delayed diagnosis is a major cost to the economy

Bipolar disorder costs the US economy approximately $20 billion annually.

17%

Bipolar's total contribution of Behavioral Health spend

Widespread misdiagnosis leads to decade long diagnostic odysseys

In the US, an estimated 56% of people with bipolar disorder do not have a diagnosis.

9.5 years

average time to diagnosis in the US

The human impact of the disease is severe

Over a third of people with undiagnosed bipolar attempt suicide, and two thirds are hospitalised.

82.9%

of adults with bipolar disorder experience serious impairment

Group therapy session

The Solution

Biological insight

Integration

Output

PUBLICATIONS

Translational Psychiatry

A machine learning algorithm to differentiate bipolar disorder from major depressive disorder using an online mental health questionnaire and blood biomarker data

2021-12-01

Jakub Tomasik, Sung Yeon Sarah Han, Giles Barton-Owen, Dan-Mircea Mirea, Nayra A. Martin-Key, Nitin Rustogi, Santiago G. Lago, Tony Olmert, Jason D. Cooper, Sureyya Ozcan, Pawel Eljasz, Grégoire Thomas, Robin Tuytten, Tim Metcalfe, Thea S. Schei, Lynn P. Farrag, Lauren V. Friend, Emily Bell, Dan Cowell & Sabine Bahn

JMIR publications

Toward an Extended Definition of Major Depressive Disorder Symptomatology: Digital Assessment and Cross-validation Study

2021-02-15

Nayra A Martin-Key; Dan-Mircea Mirea; Tony Olmert; Jason Cooper; Sung Yeon Sarah Han; Giles Barton-Owen; Lynn Farrag5  ;  Emily Bell5  ;  Pawel Eljasz1  ;  Daniel Cowell5, 6  ;  Jakub Tomasik1  ;  Sabine Bahn1, 5 

JAMA Psychiatry

Metabolomic Biomarker Signatures for Bipolar and Unipolar Depression

2023-10-25

Jakub Tomasik, Scott J. Harrison, Nitin Rustogi, Tony Olmert, Giles Barton-Owen, Sung Yeon Sarah Han, Jason D. Cooper, Paweł Eljasz, Lynn P. Farrag, Lauren V. Friend, Emily Bell, Dan Cowell, Sabine Bahn

Join us

Having published the cornerstone research in JAMA Psychiatry in October 2023, we have since validated the results in a further study with the paper due to be published Q1 2026. We're now actively engaging partners around further studies that will bring this research closer to clinical application.

All Content © 2024 Psyomics. All Rights Reserved.